FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/105077 [Registered on: 27/02/2026] Trial Registered Prospectively
Last Modified On: 24/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Shalmali glue for Cut Wounds 
Scientific Title of Study   A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF SHALMALI GLUE IN THE MANAGEMENT OF INCISED WOUND.” 
Trial Acronym  SAGE Trial 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr SNEH R RATHOD 
Designation  PG SCHOLAR 
Affiliation  Parul institute of Ayurved 
Address  Parul Institute of Ayurved, Parul university, Post. Ishwarpura - Limda, Taluka. Waghodia, Dist. Vadodara, GJ SH 158, Limda, Gujarat
Parul Institute of Ayurved, Parul university, Post. Ishwarpura - Limda, Taluka. Waghodia, Dist. Vadodara, GJ SH 158, Limda, Gujarat
Vadodara
GUJARAT
391760
India 
Phone  9099620104  
Fax    
Email  rathodsneh2898@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Hemant Toshikhane 
Designation  Professor and HOI AND DEAN 
Affiliation  Parul institute of Ayurved 
Address  Deparment of PG and PhD studies in Shalya Tantra, Parul Institute of Ayurved, Parul University, Post Limda, Waghodia, Gujarat 391760
Deparment of PG and PhD studies in Shalya Tantra, Parul Institute of Ayurved, Parul University, Post Limda, Waghodia, Gujarat 391760
Vadodara
GUJARAT
391760
India 
Phone  8469496525  
Fax    
Email  hemant.toshikhane@paruluniversity.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr Harish Daga 
Designation  Associated Professor and Head of Department 
Affiliation  Parul institute of Ayurved 
Address  Room No 403 Deparment of Shalya Tantra, Parul Institute of Ayurved, Parul University, Post Limda, Waghodia, Gujarat 391760
Room No 403 Deparment of Shalya Tantra, Parul Institute of Ayurved, Parul University, Post Limda, Waghodia, Gujarat 391760
Vadodara
GUJARAT
391760
India 
Phone  9413662079  
Fax    
Email  harish.daga26839@paruluniversity.ac.in  
 
Source of Monetary or Material Support  
PARUL AYURVED HOSPITAL Parul University Taluka Waghodia District Vadodara State Gujarat India Pincode-391760  
 
Primary Sponsor  
Name  parul institute of ayurved 
Address  Parul University, Post Limda, Waghodia, Gujarat 391760 Vadodara GUJARAT India  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr SNEH RATHOD  Parul Ayurved of Hospital  Shalya OPD No 106 Parul Ayurved Hospital, Parul University, Post Limda, Waghodia, Gujarat 391760
Vadodara
GUJARAT 
9099620104

rathodsneh2898@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMITTEE, PARUL INSTITUTE OF AYURVED  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:T148||Other injury of unspecified body region. Ayurveda Condition: VRANAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: shalmali glue, Reference: NA, Route: Topical, Dosage Form: Malahara/ Ointment/ Balm, Dose: 5(g), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator Arm (Non Ayurveda)-2-octyl cyanoacrylateRoute: Topical,Dose: 5(g), Frequency: OD,Duration : 7 days
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient with giving informed written consent.
Patient aged between 15 to 60 years.
Patients having incised wound of maximum length 5 cm and depth facia.
Patients having maximum 6 hours of duration of Vrana.
Patients without any complications.  
 
ExclusionCriteria 
Details  Patients suffering from Dustavrana (non healing wounds)
Patients with infection and malignant wounds will be excluded from the study.
Patients having deeper wound tearing muscle beneath.
Patients having profuse bleeding due to injury.
Patients having major complications like diabetes mellitus, varicose veins.
HIV, HBsAg , VDRL Positive patient.  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in wound healing assessed using wound assessment parameters (Redness, Edema, Ecchymosis, Discharge and Approximation score).
 
7 days 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary outcome
Reduction in pain assessed by Visual Analogue Scale (VAS). 
DAY 3, DAY 5, DAY 7 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   10/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  10/03/2026 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study is a randomized, open-label, comparative clinical trial designed to evaluate the efficacy and safety of Shalmali glue (Bombax ceiba gum) in the management of incised wounds. A total of 40 patients aged 15–60 years with fresh incised wounds (within 6 hours of injury) will be randomly allocated into two groups. Group A will receive topical application of Shalmali glue, and Group B will receive Dermabond glue as an active control.Wound healing will be assessed using objective parameters including redness, edema, ecchymosis, discharge, and wound approximation, along with pain assessment using the Visual Analogue Scale (VAS). Follow-up will be conducted on Day 3, Day 5, and Day 7. The study aims to determine whether Shalmali glue can serve as a safe and effective alternative to Dermabond for wound closure.
 
Close